About this trial
Proof of principle pilot study of the effect of dietary nutritional loading of protocatechunic acid (PCA) on the health and welfare of individuals with prosthetic joint infection (PJI), as measured by standard biomarkers
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
More than 3 weeks after total knee arthroplasty
One or more symptoms of injection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.
WBC count of aspiration >50,0000 cells per μL
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Oral PCA
Dietary supplementAdministration of 1,000 mg BID of oral PCA in individuals with knee prosthetic joint infection prior to revision surgery
Treatment groups
Trial outcomes
Primary outcomes
Change in Walking Pain 0-10 NRS
Walking pain change from time 0 to weekly follow-ups from 1-4
Change in CRP
Blood CRP change from time 0 to weekly follow-ups from 1-4
Change in ESR
Blood ESR change from time 0 to weekly follow-ups from 1-4
Change in WBC count in aspirate
Total WBC count change in periprosthetic aspirate
Secondary outcomes
CXCL9
Change in Immunity Factor CXCL9 from 0 to 3 months
HbA1c
Change in HbA1c from 0 to 3 months
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: